Literature DB >> 22561242

The anti-inflammatory and anti-apoptotic effects of nesfatin-1 in the traumatic rat brain.

Chong-Hui Tang1, Xiao-Jun Fu, Xin-Long Xu, Xiao-Jie Wei, Hong-Song Pan.   

Abstract

Nesfatin-1 has been demonstrated to possess anti-inflammatory and anti-apoptotic effects in the rat brain with subarachnoid hemorrhage. The study was designed to investigate the influence of nesfatin-1 on inflammatory responses and neuronal cell apoptosis after traumatic brain injury. Wistar rats were subjected to 5, 10 or 20 μg/kg of nesfatin-1 at designed time points (0.5, 2, 4 or 8h after head trauma) intraperitoneally. Rats were sacrificed at hours 2, 6 and 12, as well as day 1, 2, 3 and 5 after head trauma. The administration of 10 or 20 μg/kg of nesfatin-1 at hour 0.5 after head trauma could significantly suppress gene expressions of nuclear factor kappa-B, lessen concentrations of tumor necrosis factor-alpha, interleukin-1beta and interleukin-6, diminish caspase-3 activity as well as reduce number of apoptotic neuronal cells in traumatic rat brain tissues (P<0.05), but the administration of 5 μg/kg of nesfatin-1 not (P>0.05). Moreover, 20 μg/kg nesfatin-1 also significantly suppressed the inflammation and neuronal cell apoptosis when applied 2, 4 or 8h after head trauma. However, a clear concentration-response or time-response relationship was not found. These findings suggest that nesfatin-1 may inhibit nuclear factor kappa-B-dependent inflammatory responses, and lessen caspase-3-mediated neuronal cell apoptosis after traumatic brain injury in rats.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561242     DOI: 10.1016/j.peptides.2012.04.014

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  37 in total

1.  Nesfatin-1 Improve Spatial Memory Impairment Following Transient Global Cerebral Ischemia/Reperfusion via Inhibiting Microglial and Caspase-3 Activation.

Authors:  Sohaila Erfani; Ali Moghimi; Nahid Aboutaleb; Mehdi Khaksari
Journal:  J Mol Neurosci       Date:  2018-06-28       Impact factor: 3.444

2.  24 h nesfatin-1 treatment promotes apoptosis in cardiomyocytes.

Authors:  Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; Emad Abu-Assi; Manuel Portolés; Esther Roselló-Lletí; Miguel Rivera; Carlos Diéguez; José Ramón González-Juanatey; Francisca Lago
Journal:  Endocrine       Date:  2015-06-05       Impact factor: 3.633

3.  Relation of serum and vitreous nesfatin-1 concentrations with diabetic retinopathy.

Authors:  Rongfeng Dai; Guohua Deng; Zhuo Sun; Zhinan Liu; Yu Qian; Yan Han
Journal:  J Clin Lab Anal       Date:  2017-01-12       Impact factor: 2.352

4.  Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome.

Authors:  Figen Kir Sahin; Serap Baydur Sahin; Ulku Mete Ural; Medine Cumhur Cure; Senol Senturk; Yesim Bayoglu Tekin; Gulsah Balik; Erkan Cure; Suleyman Yuce; Aynur Kirbas
Journal:  Bosn J Basic Med Sci       Date:  2015-07-09       Impact factor: 3.363

5.  Protective effects of Nesfatin-1 peptide on cerebral ischemia reperfusion injury via inhibition of neuronal cell death and enhancement of antioxidant defenses.

Authors:  Sohaila Erfani; Ali Moghimi; Nahid Aboutaleb; Mehdi Khaksari
Journal:  Metab Brain Dis       Date:  2018-09-30       Impact factor: 3.584

Review 6.  Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson's Disease.

Authors:  Dong Dong; Junxia Xie; Jun Wang
Journal:  Neurosci Bull       Date:  2019-07-08       Impact factor: 5.203

7.  The evaluation of Nesfatin-1 levels in patients with OSAS associated with metabolic syndrome.

Authors:  O Aksu; B Aydın; D K Doguç; I Ilhan; O Ozturk; A Altuntas; H Demirkan; B K Koroglu; M N Tamer
Journal:  J Endocrinol Invest       Date:  2014-11-29       Impact factor: 4.256

8.  Nesfatin-1 alleviates extrahepatic cholestatic damage of liver in rats.

Authors:  Ali Solmaz; Osman Bilgin Gülçiçek; Candaş Erçetin; Hakan Yiğitbaş; Erkan Yavuz; Sinan Arıcı; Can Erzik; Oğuzhan Zengi; Pelin Demirtürk; Atilla Çelik; Fatih Çelebi
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

9.  Decreased levels of serum nesfatin-1 in patients with obstructive sleep apnea syndrome.

Authors:  Peng Shen; Yingying Han; Bo Cai; Yu Wang
Journal:  Sleep Breath       Date:  2014-07-24       Impact factor: 2.816

10.  Metabolic cross-talk between skeletal muscle and adipose tissue in high-intensity interval training vs. moderate-intensity continuous training by regulation of PGC-1α.

Authors:  Hossein Shirvani; Ehsan Arabzadeh
Journal:  Eat Weight Disord       Date:  2018-02-26       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.